PLYX

Polaryx Therapeutics, Inc. - Common Stock (PLYX)

About Polaryx Therapeutics, Inc. - Common Stock (PLYX)

Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.

Details

Daily high

$2.16

Daily low

$2.06

Price at open

$2.13

52 Week High

$48.91

52 Week Low

$1.86

Market cap

104.7M

Dividend yield

Volume

82,894

Avg. volume

116,964

P/E ratio

-14.56

Polaryx Therapeutics, Inc. - Common Stock News